Terapia Génica del Cáncer
TGC
Beckman Research Institute
City of Hope, Estados UnidosPublicaciones en colaboración con investigadores/as de Beckman Research Institute (3)
2023
-
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Nature Communications, Vol. 14, Núm. 1
2010
-
An increase in compliance with the surgical care improvement project measures does not prevent surgical site infection in colorectal surgery
Diseases of the Colon and Rectum, Vol. 53, Núm. 1, pp. 24-30
-
Validation of the risk index category as a predictor of surgical site infection in elective colorectal surgery
Diseases of the Colon and Rectum, Vol. 53, Núm. 5, pp. 721-727